Skip to main content

The BioCommerce Week Index: Mar 10, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(March 8, 2005)
Last Price
(
March 1, 2005
)
% Change
Agilent
A
24.36
24.48
-0.49
Applied Biosystems
ABI
20.69
20.71
-0.10
BD
BDX
58.85
59.88
-1.72
Beckman
BEC
69.88
70.45
-0.81
Bio-Rad
BIO
48.51
49.60
-2.20
Bruker
BRKR
3.78
3.66
3.28
GE
GE
36.06
35.22
2.39
Harvard Bio
HBIO
4.43
4.22
4.98
Invitrogen
IVGN
71.66
70.56
1.56
Molecular Devices
MDCC
20.05
20.93
-4.20
PerkinElmer
PKI
23.01
22.20
3.65
Sigma
SIAL
63.79
62.37
2.28
Stratagene
STGN
7.39
6.82
8.36
Thermo
TMO
27.69
27.32
1.35
Waters
WAT
49.32
48.50
1.69
Index Average
35.30
35.13
0.48

 

Stratagene, Harvard Bio Lead as BCW Index Rises a Half Percent

Lifted by their fourth-quarter financial reports issued early this week, Stratagene and Harvard Bioscience shares closed up 8 percent and 5 percent, respectively, for the five-day period ending Tuesday.

The two companies were among nine of the 15 companies in the BioCommerce Week Index whose shares increased during the week.

PerkinElmer shares improved 3.7 percent for the week, followed by Bruker, which 3 percent after releasing its fourth-quarter financials and a raft of new products at last week's Pittcon (see article).

Molecular Devices led share-price losers with a 4 percent drop.

Overall, the Index finished up 0.5 percent, in positive territory for the second straight week with a close of $35.30. The Index has improved 13.5 percent since it debuted on Sept. 9, and reached a high-water mark of $36.10 on Feb. 8.

For the week, the BCW Index matched the Dow and the S&P 500, which were up 5 percent for the period, and outperformed the Nasdaq index, which closed level for the week, the Amex biotech index, which fell 3 percent, and the Amex pharma index, which was down over 0.5 percent.

 

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.